Dr. Jennifer Foster is a pediatric oncologist at Baylor College of Medicine/Texas Children’s Cancer and Hematology Center with clinical and research expertise in pediatric solid tumors and clinical pharmacology. She serves as Director of the Solid Tumor Programs, Clinical Director of the Neuroblastoma Program, and Assistant Director of the Developmental Therapeutics Program at Texas Children’s Cancer Center, one of the largest pediatric cancer center in the United States.
Her clinical and research interests are to bring novel therapies into early phase clinical trials for patients with neuroblastoma and other solid tumors, as well as to mitigate toxicities of therapy. As such, she is dual board certified in Pediatric Hematology-Oncology and Clinical Pharmacology. She has expertise in moving novel agents from the pre-clinical arena to the implementation of early phase clinical trials. She successfully completed the pre-clinical evaluation for the first-in-class NEDD8 activating enzyme inhibitor pevonedistat and partnered with Takeda to develop and conduct the Phase 1 clinical trial through the Children’s Oncology Group (COG).
As the site Principal Investigator for the National Cancer Institute’s Pediatric Early Phase Clinical Trials Network, she is responsible for the implementation and conduct of these trials at our institution, and is actively investigating novel agents through our Developmental Therapeutics pre-clinical program with the goal of incorporating them into future clinical trials.
American Board of Pediatrics
American Board of Pediatrics - Pediatric Hematology/Oncology
American Board of Clinical Pharmacology - Clinical Pharmacology